AVITA Medical Stock (NASDAQ: RCEL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 163.65K |
Day Range | - - - |
52 Wk Range | 7.51 - 18.93 |
Market Cap | $274.45M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 64 |
Short Interest | 5.65% |
Days to Cover | 14.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AVITA Medical (NASDAQ:RCEL) through any online brokerage.
Other companies in AVITA Medical’s space includes: Zura Bio (NASDAQ:ZURA), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), PepGen (NASDAQ:PEPG) and Adaptimmune Therapeutics (NASDAQ:ADAP).
AVITA Medical has a consensus price target of $24.25.
The stock price for AVITA Medical (NASDAQ: RCEL) is $10.56 last updated September 23, 2024 at 4:01 PM EDT.
There are no upcoming dividends for AVITA Medical.
AVITA Medical’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for AVITA Medical.
AVITA Medical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.